I
527.61
-10.19 (-1.89%)
Previous Close | 537.80 |
Open | 533.21 |
Volume | 1,445,125 |
Avg. Volume (3M) | 1,233,259 |
Market Cap | 187,923,595,264 |
Price / Earnings (TTM) | 84.69 |
Price / Earnings (Forward) | 69.44 |
Price / Sales | 24.70 |
Price / Book | 12.32 |
52 Weeks Range | |
Earnings Date | 21 Jan 2025 - 27 Jan 2025 |
Profit Margin | 28.51% |
Operating Margin (TTM) | 28.33% |
Diluted EPS (TTM) | 6.20 |
Quarterly Revenue Growth (YOY) | 16.90% |
Quarterly Earnings Growth (YOY) | 35.90% |
Total Debt/Equity (MRQ) | 1.91% |
Current Ratio (MRQ) | 4.30 |
Operating Cash Flow (TTM) | 1.82 B |
Levered Free Cash Flow (TTM) | 637.52 M |
Return on Assets (TTM) | 7.95% |
Return on Equity (TTM) | 15.97% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
Medical Instruments & Supplies (Global) | Mixed | Mixed | |
Stock | Intuitive Surgical, Inc. | Bullish | Bullish |
Stockmoo Score
0.3
Analyst Consensus | 1.5 |
Insider Activity | -3.5 |
Price Volatility | -0.5 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 4.0 |
Average | 0.30 |
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Large Growth |
% Held by Insiders | 0.52% |
% Held by Institutions | 89.00% |
52 Weeks Range | ||
Price Target Range | ||
High | 575.00 (JP Morgan, 8.98%) | Buy |
Median | 549.00 (4.05%) | |
Low | 490.00 (Evercore ISI Group, -7.13%) | Hold |
Average | 545.64 (3.42%) | |
Total | 10 Buy, 1 Hold | |
Avg. Price @ Call | 508.95 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
BTIG | 18 Oct 2024 | 535.00 (1.40%) | Buy | 521.15 |
14 Oct 2024 | 518.00 (-1.82%) | Buy | 487.61 | |
Baird | 18 Oct 2024 | 565.00 (7.09%) | Buy | 521.15 |
Evercore ISI Group | 18 Oct 2024 | 490.00 (-7.13%) | Hold | 521.15 |
01 Oct 2024 | 475.00 (-9.97%) | Hold | 484.76 | |
Piper Sandler | 18 Oct 2024 | 538.00 (1.97%) | Buy | 521.15 |
RBC Capital | 18 Oct 2024 | 555.00 (5.19%) | Buy | 521.15 |
08 Oct 2024 | 525.00 (-0.49%) | Buy | 480.79 | |
Stifel | 18 Oct 2024 | 525.00 (-0.49%) | Buy | 521.15 |
Wells Fargo | 18 Oct 2024 | 549.00 (4.05%) | Buy | 521.15 |
Raymond James | 14 Oct 2024 | 540.00 (2.35%) | Buy | 487.61 |
Truist Securities | 14 Oct 2024 | 570.00 (8.03%) | Buy | 487.61 |
JP Morgan | 11 Oct 2024 | 575.00 (8.98%) | Buy | 484.78 |
Citigroup | 22 Aug 2024 | 560.00 (6.14%) | Buy | 490.43 |
Show more |
Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
---|---|---|---|---|
CURET MYRIAM | - | 537.07 | -13,466 | -7,232,185 |
DESANTIS ROBERT | - | 535.75 | -239 | -128,044 |
SAMATH JAMIE | - | 536.10 | -23,172 | -12,430,431 |
Aggregate Net Quantity | -36,877 | |||
Aggregate Net Value ($) | -19,790,660 | |||
Aggregate Avg. Buy ($) | - | |||
Aggregate Avg. Sell ($) | 536.26 |
Name | Holder | Date | Type | Quantity | Price | Value ($) |
---|---|---|---|---|---|---|
CURET MYRIAM | Officer | 12 Nov 2024 | Automatic sell (-) | 13,466 | 537.07 | 7,232,185 |
CURET MYRIAM | Officer | 12 Nov 2024 | Option execute | 13,466 | - | - |
DESANTIS ROBERT | Officer | 11 Nov 2024 | Automatic sell (-) | 239 | 535.75 | 128,044 |
DESANTIS ROBERT | Officer | 11 Nov 2024 | Option execute | 239 | - | - |
SAMATH JAMIE | Officer | 11 Nov 2024 | Automatic sell (-) | 269 | 535.75 | 144,117 |
SAMATH JAMIE | Officer | 11 Nov 2024 | Option execute | 269 | - | - |
SAMATH JAMIE | Officer | 08 Nov 2024 | Automatic sell (-) | 22,903 | 536.45 | 12,286,314 |
SAMATH JAMIE | Officer | 08 Nov 2024 | Option execute | 22,903 | - | - |
Date | Type | Details |
---|---|---|
28 Oct 2024 | Announcement | Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner |
17 Oct 2024 | Announcement | Intuitive Announces Third Quarter Earnings |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |